XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net income / (loss) from continuing operations $ 247,000 $ (420,000)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:    
Depreciation and amortization 151,000 195,000
Equity compensation expense 11,000 92,000
Change in assets and liabilities:    
Accounts receivable (1,341,000) 707,000
Inventories 686,000 (405,000)
Prepaid expenses and other assets (47,000) 333,000
Trade payables (331,000) (112,000)
Accrued liabilities (737,000) (87,000)
Net cash provided by (used in) operating activities (1,361,000) 303,000
Cash flows from investing activities:    
Purchases of property, plant and equipment (94,000) (94,000)
Net cash (used in) provided by investing activities (94,000) (94,000)
Cash flows from financing activities:    
Proceeds from issuance/(Repayment) of long-term debt and revolving line of credit 1,409,000 (221,000)
Net cash used in financing activities 1,409,000 (221,000)
Net (decrease) / increase in cash and cash equivalents (46,000) (12,000)
Cash and cash equivalents at beginning of period 146,000 66,000
Cash and cash equivalents at end of period 100,000 54,000
Supplemental disclosure of cash flow information:    
Cash payments for interest 259,000 169,000
Accrued Divided and Accretion on preferred stock 11,000 404,000
Lease right-of-use assets and lease liability 747,000
Conversion of notes and deposits into common stock 885,000
Conversion of Series B preferred stock into common stock $ 1,500,000